Customize
Quick Links
Past Events

Accreditation/
Credit Designation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Physicians’ Education Resource®, LLC and Pharmacy Times Continuing Education. Physicians’ Education Resource®, LLC is accredited by the ACCME to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC designates this live activity for a maximum of 26.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 26.75 Contact Hours.

ACCREDITATION/CREDIT DESIGNATION FOR PHARMACISTS

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education (CPE). This activity is approved for a maximum of 22.75 contact hours under the ACPE universal activity numbers:

November 7, 2018, Conference Day 1 – 0290-9999-18-099-L01-P (7.75 contact hours)

November 8, 2018, Conference Day 2 – 0290-9999-18-100-L01-P (7.0 contact hours)

November 9, 2018, Conference Day 3 – 0290-9999-18-101-L01-P (8.0 contact hours)

The activity is available for continuing education (CE) credit through December 9, 2018.

Acknowledgment of Commercial Support

This activity is supported by educational grants from AstraZeneca, Celgene Corporation, Daiichi Sankyo, Inc., Eisai, Exelixis, Inc., Genomic Health, Inc., Ferring Pharmaceuticals, Inc., Incyte Corporation, Jazz Pharmaceuticals, Novartis Pharmaceuticals Corporation, Novocure, Pfizer, Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Regeneron, Seattle Genetics, Inc., Takeda Oncology, and Taiho Oncology, Inc.

About
Accreditation
Privacy Policy
Terms & Conditions
Executive Board
Journal
Faculty Portal
Contact
Facebook
Twitter
LinkedIn
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 1-609-378-3701

Copyright © 2018
Physicians’ Education Resource ®, LLC.
All rights reserved.

36th Annual CFS®: Innovative Cancer Therapy for Tomorrow

36th Annual CFS®: Innovative Cancer Therapy for Tomorrow


CME Events

Wednesday, November 7, 2018
6:00 PM – 7:30 PM
Bring Your Own Case (BYOC™)! Addressing Challenging Clinical Scenarios in Breast Cancer

Wednesday, November 7, 2018
1:40 PM – 3:10 PM
Medical Crossfire®: An Oncologist’s Guide to Using Biosimilars in Breast Cancer: Right Patient, Right Time, Right Treatment

Thursday, November 8, 2018
9:00 AM – 10:00 AM
Medical Crossfire®: A Critical Assessment of Current and Emerging Data Sets to Move Treatment of Triple-Negative Breast Cancer Forward

Thursday, November 8, 2018
2:00 PM – 3:30 PM
Medical Crossfire®: Evaluating Immuno-Oncology Strategies Across Tumor Types

Friday, November 9, 2018
2:10 PM – 3:40 PM
Medical Crossfire®: How Do You Use Liquid Biopsies in NSCLC?


Non-CME Events

Lunch sponsored by Celgene
Wednesday, November 7
Time: 12:25 PM- 1:40 PM
Location: Majestic Complex
Speaker: Dr. Brion Randolph
IMiD® FOUNDATION in MYELOMA THERAPY: REVLIMID® AND POMALYST®CLINICAL DATA

Lunch sponsored by Pfizer
Wednesday, November 7
Time: 12:25 PM- 1:40 PM
Location: Shubert Complex
Speaker: Stephen Malamud, MD and Patient Ambassador, Tami
Make a First-in-Class Oral Therapy Your Partner of Choice for the treatment of Women With HR+/HER2 – Metastatic Breast Cancer

Dinner sponsored by Taiho
Wednesday, November 7
Time: 5:45 PM- 7:15 PM
Location: Marquis Salon C
Speaker: Wayne Keiser, MD
LONSURF® (trifluridine and tipiracil) for the Treatment of Refractory Metastatic Colorectal Cancer

Dinner sponsored by Jazz Pharmaceuticals
Wednesday, November 7
Time: 7:00 PM- 8:30 PM
Location: Blue Fin Restaurant- 1567 Broadway, New York, NY 10036
Speaker: James McCloskey II, MD
Advancements in the treatment of newly-diagnosed AML

Lunch sponsored by Merck
Thursday, November 8
Time: 12:45 PM- 2:00 PM
Location: Majestic Complex
Speaker: TBA
A First-line Treatment Option for Patients With Metastatic NSCLC: Clinical Data and Patient Case

Lunch sponsored by Lilly Oncology
Thursday, November 8
Time: 12:45 PM- 2:00 PM
Location: Shubert Complex
Speaker: Peter A. Kaufman, MD
A Treatment Option for Patients With HR+/HER2- Advanced or Metastatic Breast Cancer
© Lilly USA, LLC 2018. All rights reserved.

Dinner sponsored by Exelixis
Thursday, November 8
Time: 5:30 PM- 7:00 PM
Location: Marquis Salon C
Speaker: Jason Suh, MD
CABOMETYX®: Treatment for Patients With Advanced Renal Cell Carcinoma

Lunch sponsored by AstraZeneca
Friday, November 9
Time: 12:55 PM- 2:10 PM
Location: Majestic Complex
Speaker: Tracey Evans
Transforming the Treatment of NSCLC: Options for First-Line Treatment of Metastatic EGFR Mutation-Positive Disease and Immunotherapy for Stage III Unresectable Disease

Lunch sponsored by Lilly Oncology
Friday, November 9
Time: 12:55 PM- 2:10 PM
Location: Shubert Complex
Speakers: Roy Herbst, MD, Cathy Eng, MD, David Ilson, MD, Joshua Bauml, MD
TBA

Dinner sponsored by Takeda
Friday, November 9
Time: 5:30 PM- 7:00 PM
Location: Marquis Salon A
Speaker: Mark Socinski, MD
ALUNBRIG® (brigatinib) for the Treatment of ALK+ NSCLC







Become a Member

Forgot Password?
Filter By